136 related articles for article (PubMed ID: 15809976)
1. Abnormal expression of period 1 (PER1) in endometrial carcinoma.
Yeh KT; Yang MY; Liu TC; Chen JC; Chan WL; Lin SF; Chang JG
J Pathol; 2005 May; 206(1):111-20. PubMed ID: 15809976
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR.
Shih MC; Yeh KT; Tang KP; Chen JC; Chang JG
Mol Carcinog; 2006 Oct; 45(10):732-40. PubMed ID: 16683245
[TBL] [Abstract][Full Text] [Related]
3. Disturbance of circadian gene expression in hepatocellular carcinoma.
Lin YM; Chang JH; Yeh KT; Yang MY; Liu TC; Lin SF; Su WW; Chang JG
Mol Carcinog; 2008 Dec; 47(12):925-33. PubMed ID: 18444243
[TBL] [Abstract][Full Text] [Related]
4. Disturbance of circadian gene expression in endometrial cancer: detection by real-time quantitative RT-PCR.
Shih HC; Choo KB; Chang TJ; Yang MY; Shih MC; Yeh KT; Liu TC; Lin SF; Chang JG
Oncol Rep; 2005 Dec; 14(6):1533-8. PubMed ID: 16273251
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.
Chen ST; Choo KB; Hou MF; Yeh KT; Kuo SJ; Chang JG
Carcinogenesis; 2005 Jul; 26(7):1241-6. PubMed ID: 15790588
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of JUNB gene in hepatocellular carcinoma.
Chang YS; Yeh KT; Yang MY; Liu TC; Lin SF; Chan WL; Chang JG
Oncol Rep; 2005 Mar; 13(3):433-8. PubMed ID: 15706412
[TBL] [Abstract][Full Text] [Related]
7. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
Gery S; Komatsu N; Baldjyan L; Yu A; Koo D; Koeffler HP
Mol Cell; 2006 May; 22(3):375-82. PubMed ID: 16678109
[TBL] [Abstract][Full Text] [Related]
8. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
9. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.
Bhawal UK; Tsukinoki K; Sasahira T; Sato F; Mori Y; Muto N; Sugiyama M; Kuniyasu H
Oncol Rep; 2007 Oct; 18(4):817-24. PubMed ID: 17786341
[TBL] [Abstract][Full Text] [Related]
10. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.
Krugluger W; Brandstaetter A; Kállay E; Schueller J; Krexner E; Kriwanek S; Bonner E; Cross HS
Cancer Res; 2007 Aug; 67(16):7917-22. PubMed ID: 17699798
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer.
Gery S; Komatsu N; Kawamata N; Miller CW; Desmond J; Virk RK; Marchevsky A; Mckenna R; Taguchi H; Koeffler HP
Clin Cancer Res; 2007 Mar; 13(5):1399-404. PubMed ID: 17332281
[TBL] [Abstract][Full Text] [Related]
12. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
13. Effects of light and food schedules on liver and tumor molecular clocks in mice.
Filipski E; Innominato PF; Wu M; Li XM; Iacobelli S; Xian LJ; Lévi F
J Natl Cancer Inst; 2005 Apr; 97(7):507-17. PubMed ID: 15812076
[TBL] [Abstract][Full Text] [Related]
14. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells.
Hsu MC; Huang CC; Choo KB; Huang CJ
Biochem Biophys Res Commun; 2007 Aug; 360(1):257-62. PubMed ID: 17592726
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract][Full Text] [Related]
17. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
Eisele L; Prinz R; Klein-Hitpass L; Nückel H; Lowinski K; Thomale J; Moeller LC; Dührsen U; Dürig J
Eur J Haematol; 2009 Oct; 83(4):320-7. PubMed ID: 19500131
[TBL] [Abstract][Full Text] [Related]
18. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.
Yang MY; Chang JG; Lin PM; Tang KP; Chen YH; Lin HY; Liu TC; Hsiao HH; Liu YC; Lin SF
Cancer Sci; 2006 Dec; 97(12):1298-307. PubMed ID: 16999817
[TBL] [Abstract][Full Text] [Related]
20. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.
Yang X; Wood PA; Oh EY; Du-Quiton J; Ansell CM; Hrushesky WJ
Breast Cancer Res Treat; 2009 Sep; 117(2):423-31. PubMed ID: 18651214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
